Beijing Watson Innovation Biotechnology

Beijing Watson Innovation Biotechnology is a subsidiary of Walvax Biotechnology (300142.SZ) focused on the industrialization and manufacturing of innovative vaccines. Based in Beijing's Daxing Bio-medicine Industry Base, the company operates advanced manufacturing facilities for high-end vaccine products. Its primary focus includes the production of a 9-valent Human Papillomavirus (HPV) vaccine using a recombinant yeast VLP platform, as well as COVID-19 vaccines utilizing adenovirus vector and recombinant protein technologies. The company aims to break international monopolies on patent vaccines and supply the global market through partnerships with organizations like the WHO and the Bill & Melinda Gates Foundation. By leveraging its parent company's R&D strengths, Beijing Watson Innovation serves as a critical hub for the large-scale production of next-generation biologicals.